Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Butyrate: Connecting the gut-lung axis to the management of pulmonary disorders
Renan Oliveira Corrêa, Pollyana Ribeiro Castro, René Moser, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Faecalibacterium: a bacterial genus with promising human health applications
Rebeca Martín, David Ríos-Covián, Eugénie Huillet, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 4
Open Access | Times Cited: 178
The causality between intestinal flora and allergic diseases: Insights from a bi-directional two-sample Mendelian randomization analysis
Qiubai Jin, Feihong Ren, Dan Dai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
Dysbiosis and extraintestinal cancers
Rui He, Ping-Qian Qi, Lin-Zhen Shu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS—induced Mouse Model of Chronic Obstructive Pulmonary Disease
Huan‐Ting Shen, Yi‐Ting Fang, Wan-Hua Tsai, et al.
Probiotics and Antimicrobial Proteins (2024)
Open Access | Times Cited: 7
The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review
Mahmoud Yousef, Mlaak Rob, Sanish Varghese, et al.
Life Sciences (2024) Vol. 342, pp. 122535-122535
Open Access | Times Cited: 6
Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study
Yingchen Li, Ke Wang, Yuchong Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 16
The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective
Xuelin Wang, Liming Hou, Meng Cui, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Lactiplantibacillusplantarum APsulloc331261 (GTB1™) promotes butyrate production to suppress mucin hypersecretion in a murine allergic airway inflammation model
Hye‐Shin Kim, Bobae Kim, Wilhelm H. Holzapfel, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)
Lindsay M. Forbes, Natalie Bauer, Aritra Bhadra, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
Ozone-induced lung injury and inflammation: Pathways and therapeutic targets for pulmonary diseases caused by air pollutants
Remo Castro Russo, Dieudonnée Togbe, Isabelle Couillin, et al.
Environment International (2025), pp. 109391-109391
Open Access
Lacticaseibacillus rhamnosus CP-1 mitigates LPS-induced acute lung injury in mice via TLR/NF-κB pathway and gut microbiota modulation
J.-S. Lin, Zhonghua Wang, Jiaojiao Han, et al.
Food Bioscience (2025), pp. 106429-106429
Closed Access
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Vicky Yao, Nairui Fan, Shuxia Ma, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
Giuseppe Lo Russo, Arsela Prelaj, James M. Dolezal, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006833-e006833
Open Access | Times Cited: 10
Lactobacillus rhamnosus (LR) ameliorates pulmonary and extrapulmonary acute respiratory distress syndrome (ARDS) via targeting neutrophils
Leena Sapra, Chaman Saini, Sneha Das, et al.
Clinical Immunology (2023) Vol. 258, pp. 109872-109872
Closed Access | Times Cited: 9
Indole-3-acetic acid ameliorates dextran sulfate sodium-induced colitis via the ERK signaling pathway
Xinyan Qu, Yingying Song, Qingjun Li, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 3, pp. 288-299
Closed Access | Times Cited: 3
Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study
Zhiting Chen, Zhe Wang, Hao Ma, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease
Eun Yeong Lim, Eun‐Ji Song, Hee Soon Shin
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 9, pp. 1111-1118
Open Access | Times Cited: 5
Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation
Zi-Xuan Cheng, Jing Zhang
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (2024) Vol. 11, Iss. 3, pp. 311-325
Open Access | Times Cited: 1
Anti-tuberculosis effect of microbiome therapeutic PMC205 in extensively drug-resistant pulmonary tuberculosis in vivo
Hoonhee Seo, Youjin Yoon, Sukyung Kim, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 3, pp. 107274-107274
Open Access | Times Cited: 1
Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial
Maria Letizia Giancola, Andrea Fontana, Concetta Panebianco, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1443-1443
Open Access | Times Cited: 1
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?
Torsten P. M. Scheithauer, R.C. Montijn, Arnout Mieremet
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Curcumin and butyrate induce fibroblast senescence without the emergence of fibrosis biomarkers
Siwei Chu, Natali Joma, Hui Wen Yong, et al.
Aspects of Molecular Medicine (2023) Vol. 2, pp. 100021-100021
Open Access | Times Cited: 2
Butyrate Protects against SARS-CoV-2-Induced Tissue Damage in Golden Hamsters
Huan Yu, Lunzhi Yuan, Zhigang Yan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14191-14191
Open Access | Times Cited: 2
Immune mRNA Expression and Fecal Microbiome Composition Change Induced by Djulis (Chenopodium formosanum Koidz.) Supplementation in Aged Mice: A Pilot Study
B. Villanueva, Huai-Ying Huang, Yu‐Chang Tyan, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1545-1545
Open Access
Investigating disturbances of the core material system in the lung-gut axis of COPD based on the transcriptomics-metabolomics-microbiomics integration strategy
Tianyang Wang, Fang Wang, Ruinan Ren, et al.
Arabian Journal of Chemistry (2024) Vol. 18, Iss. 1, pp. 106056-106056
Open Access
Page 1 - Next Page

Scroll to top